Drug companies are abandoning antibiotic research to make more money elsewhere. Yet another reason why we need a publicly owned company.
Dana Brown
Dana Brown is deputy director of The Next System Project at the Democracy Collaborative.

Three weeks ago, we took programmatic advertising off our site. To keep it that way, we need 33 new monthly donors by May 6th. A generous donor has stepped up to match every gift to help us hit our goal.
Your support will go twice as far.
Every gift to the Prospect is matched. Help us prove that paywall-free journalism works.

Get the latest stories from the Prospect delivered right to your inbox for the in-depth analysis you need.

Get the latest stories from the Prospect delivered right to your inbox for the in-depth analysis you need.
Dana Brown is deputy director of The Next System Project at the Democracy Collaborative.
Drug companies are abandoning antibiotic research to make more money elsewhere. Yet another reason why we need a publicly owned company.